LEAVE NO THING BEHIND

Minimally Invasive Micro Sclerostomy (MIMS®) is a Stentless, simple and fast Glaucoma treatment which effectively lowers the intraocular pressure (IOP) without the need for major invasive surgery.

A Minimal invasive and Stent-less Treatment Glaucoma Innovation

MIMS® is a rapid and minimal invasive procedure at the forefront of interventional glaucoma treatments. Fewer post-op complications allow for effective IOP management. MIMS® is designed to create a sclerostomy similar to trabeculectomy, the gold standard for incisional glaucoma surgery, but with an approach that is less invasive, in terms of tissue damage, and without any implanted material (stent-less). Therefore, complications relating to hyphema and hypotony (such as flat anterior chamber, choroidal effusions and detachments), which are observed in trabeculectomy are expected to occur at a lower incidence and severity with MIMS®. Other post-operative events are expected to be similar to other minimally invasive, stent-less glaucoma treatments.

How MIMS® Works

Minimally Invasive Micro Sclerostomy (MIMS®) is fast, accessible and effective. MIMS® is intended for the reduction of elevated IOP. It works by inserting a specially designed cutting tool into the sclera and removing a small channel of tissue. This channel will remain open and continuously drain, effectively reducing IOP.

MIMS® advantages:

  • A minimal surgical intervention into the eye with the
  • consequent lower risk of hypotony or injury to the surrounding ocular tissues
  • enables stable post-operative IOP levels
  • Takes short surgical time (few minutes)
  • MIMS® application is simple and easy

A Ready-to-Use Surgical System

MIMS® is a lightweight surgical system intended for use by trained professional ophthalmologists. It’s easy to use and learn, intuitive to operate and requires fewer staff to assist in non-surgical environments. A central control touchscreen demonstrates the surgical parameters, and a foot pedal initiates the precise handheld cutting tool movement.


Precision Glaucoma Treatment Technology

Learn more about Sanoculis and MIMS® surgical device innovation.

Outstanding Clinical Performance

2:03±0:43

Min Procedure
duration

38%

IOP Reduction after 12
Months

85%

Medication reduction
at 12 mo.

ZERO Major/serious intra/post-op ocular complications

Major intra/post-op
complications

MIMS® Testimonials

"The procedure is effective in reducing IOP without medication or complications, improving lives and simplifying treatments for glaucoma."

Dr. Ike Ahmed

Ophthalmology MD, Canada

"The procedure is effective in reducing the IOP. It is minimally invasive, fast and does not require any stitches or stents under topical local anesthesia. It lasts several minutes and relieves the patient from the need for medications."

Dr. Lilach Drori

Head of Glaucoma Service, Barzilai Medical Center, Israel

"The procedure is quick, easy to perform and so far, the preliminary results are good and without complications. Every good Cataract surgeon can perform the MIMS surgery combined with Phaco"

Dr. Beatrice Tiosano

Director of Ophthalmology, Hillel Yaffe Medical Center, Israel

"Having conducted post-op follow-up on patients who have undergone this surgery, the IOP was considerably reduced"

Dr. Natalya Kovalyuk

Head of Glaucoma and Cataract Service

News & Publications

"Congratulations to Prof. Veva De Groot and the amazing team at ZNA hospital in Antwerpen, Dr. Kathy Hondeghem and Dr. Sylvie Devloo for successfully completing MIMS® wet lab training and conducting MIMS® procedures."

Read More

"MIMS® in Germany! Thank you very much Prof. Anselm Junemann and Prof. Esther Hoffmann. It is a great pleasure and honor for Sanoculis to work and cooperate with you"

Read More

"MIMS – An Innovative New Surgical Procedure For Glaucoma"

Read More

"Glaucoma Devices Provide Impressive IOP-lowering Results"

Read More

"MIMS® – a new surgical procedure for glaucoma – simplifies treatment and keeps patients’ options open"

Read More

Global Distribution & Partners

Israel

Skymed

Hafrat 2, Yavne, Israel 8122702

072-2555-240

service@skymed.co.il

http://www.skymed.co.il/

Israel

Europe

Learn

OUR VISION

INTERVENTIONAL GLAUCOMA

CLINICAL TRIAL DATA

Resources

TECHNICAL SPECIFICATIONS

DISTRIBUTORS LOGIN

PRIVACY POLICY & TERMS

Company

mims@sanoculis.com

+972 03 550 3432

10 Landau, Kiryat Ono, 5555110, Israel

MIMS® is a registered Trademark © 2021 Sanoculis LTD. MIMS® is a CE marked device (under MDD 93/42/EEC). MIMS® is an investigational device, limited by Federal (Or United States) law to investigational use.

Made By
Guided by

This site uses cookies to improve visitor experience and analyze web traffic. We may share usage data with analytics partners to enhance and optimize. By clicking accept, you consent to store on your device technologies described in our privacy policy and terms of use. Thank you. privacy policy & terms of use